New Starters in London, January 2024
Windrose Consulting Group are pleased to welcome the latest members of our team into the UK office; Katharine Gilbert, Myrto Vouga and Sharon Lau.
EU HTA: Can a one-size-fits all approach really work, and how can manufacturers prepare?
EU HTA marks the beginning of efforts to streamline and harmonize the Health Technology Assessment (HTA) processes and outcomes across European Union (EU) member states. Despite its imminent rollout (from January 2025*), key uncertainties remain around its implementation and likely success.
UnitedHealthcare Begins Eliminating Prior Authorization Requirements Across Their Major Plans
On September 1st, 2023, UnitedHealthcare completed its first phase as part of a two-phase approach to eliminate prior authorization requirements for various procedures and services across their commercial, Medicare, and Medicaid plans
CMS Requires Registry to Access FDA-approved Alzheimer’s Treatments:
The Centers for Medicare & Medicaid Services (CMS) announced on June 22nd a detailed plan regarding its coverage of new Alzheimer’s treatments, following the full approval of Eisai’s Leqembi by the FDA.
Promotions at Windrose
Maja Warrum has been promoted to Senior Engagement Manager; Mattia Belloni has been promoted to Engagement Manager; Georgina Powell has been promoted to Senior Consultant; and both Paige Stitzel and Steven Lin have been promoted to Senior Analyst roles.
Katherine Yang joins Windrose in the UK
Windrose Consulting Group are pleased to welcome our latest hire to the UK office, Katherine Yang, as a Senior Analyst.
Windrose Consulting Group 2023 All Hands meeting in Philadelphia
Our theme for the 2023 All Hands meeting was “Embracing Growth”, and the team had a busy week full of engagement, connection, and camaraderie.
Mickey Popli joins Windrose in the US
Windrose Consulting Group are pleased to welcome our latest Senior hire, Mickey Popli, to our US office as a Principal.
Six new analysts join Windrose US
Windrose Consulting Group are pleased to welcome six new Analysts: Anusha Keshireddy, Daniel Jackson, Janani Gurumurthy, Noah Blase, Rohit Palekar, and Witt Holmes, into the Philadelphia office.
Global News Roundup: Q2 2023
We are pleased to release the next edition of our Windrose Consulting Group: Global News Roundup for Q2 2023.
Pricing and Market Access (P&MA) Challenges in Switzerland
In 2019, the Swiss Federal Council modified the Therapeutic Products Act (TPA) to facilitate market access, improve drug safety, and increase transparency in Switzerland’s P&MA system.
Tyler Will joins Windrose in Philadelphia
Windrose Consulting Group are pleased to welcome Tyler Will to our Philadelphia office.
Q&As with our Summer interns at Windrose
In this Q&A, we are featuring our Summer Interns, Amy Brinster, Aashray Gupta and Isaac Tolley
Giulio Mazzotta and Andrey Buzuk join Windrose Switzerland
Windrose Consulting Group are pleased to welcome two new starters, Giulio Mazzotta and Andrey Buzuk into our Swiss office.
New Windrose office in London
We are excited to announce that, due to our remarkable growth, we have moved to a bigger and better office in the heart of London!
China Market Access Through Cross-border Partnership: Opportunities and Challenges for Western Pharmaceuticals
Since entering the World Trade Organization, China’s Pharmaceutical industry has experienced rapid growth in value, from $123.7 billion in 2016 to an estimated $573.5 billion in 2022
Global News Roundup: Q1 2023
We are pleased to release the next edition of our Windrose Consulting Group: Global News Roundup for Q1 2023.
Zameer Merchant, Anaïs Frappé, Lynn Danker and Daisy Pharoah promoted
We are delighted to announce four promotions at Windrose Consulting Group. Both Zameer Merchant and Anaïs Frappé have been promoted to Senior Principal; Lynn Danker has been promoted to Senior Consultant and Daisy Pharoah is now a Senior Analyst.
Greg Certo, joins the Windrose office in Philadelphia
Windrose Consulting Group are pleased to welcome a new starter, Greg Certo, to our Philadelphia office as an Engagement Manager.
Developing a Successful Biopharmaceutical Pricing & Market Access Strategy
Windrose Consulting Group collaborate with Cambridge University on a Executive education course on Pricing and Market Access Strategy.